Table 1.
Correlation of miR-145-5p Expression with Clinicopathological Characteristics in Hepatocellular Carcinoma
Variables | Cases (n=150) | miR-145-5p Expression | P value | |
---|---|---|---|---|
High (n = 75) | Low (n = 75) | |||
>0.386 | <0.386 | |||
Age (years) | 0.407 | |||
≤55 | 62 | 34 | 28 | |
>55 | 88 | 41 | 47 | |
Sex | 0.449 | |||
Male | 113 | 59 | 54 | |
Female | 37 | 16 | 21 | |
Tumor size (cm) | 0.019a | |||
≤5 | 91 | 53 | 38 | |
>5 | 59 | 22 | 37 | |
Cellular differentiation | 0.022a | |||
I–II | 113 | 63 | 50 | |
ш–IV | 37 | 12 | 25 | |
Tumor encapsulation | 0.022a | |||
Present | 48 | 31 | 17 | |
Absent | 102 | 44 | 58 | |
HBV infection | 0.464 | |||
Present | 109 | 52 | 57 | |
Absent | 41 | 23 | 18 | |
Portal vein tumor embolus | 0.018a | |||
Present | 42 | 14 | 28 | |
Absent | 108 | 61 | 47 | |
TNM tumor stage | 0.013a | |||
I–II | 103 | 59 | 44 | |
ш–IV | 47 | 16 | 31 |
Abbreviations: TNM, tumor-node-metastasis; HBV, hepatitis B virus; a Statistically significant.